Greenland Mines Ltd, formerly known as Klotho Neurosciences, Inc., reported significant financial developments in its latest 10-Q filing for the quarter ending June 30, 2026. The company recorded a net loss of $3.7 million for the quarter, a decrease from a loss of $4.1 million in the same period last year. For the first half of 2026, the net loss was $17.5 million, compared to $6.3 million for the first half of 2025. The increase in losses is attributed to higher operating expenses, particularly in professional fees and research and development, following the acquisition of Greenland Mines Corp. in March 2026.
Total operating expenses for the second quarter of 2026 reached approximately $5.5 million, a 189% increase from $1.9 million in the prior year. Professional fees surged to $3.9 million, up from $0.9 million, largely due to costs associated with public company reporting and strategic initiatives. General and administrative expenses decreased slightly to $578,000, while research and development expenses rose to $401,000, reflecting ongoing investments in biotechnology programs. The company also incurred exploration and evaluation expenses of $561,000 related to its Skaergaard Project in Greenland, marking the first such expenses since the acquisition.
In terms of strategic developments, Greenland Mines Ltd has expanded its operations to include mining, following the acquisition of an 80% interest in the Skaergaard Project, which is one of the largest undeveloped palladium, gold, and platinum deposits globally. The company has not yet established any mineral reserves but reported estimated indicated and inferred mineral resources in its recent technical report. Additionally, on June 22, 2026, Greenland Mines completed a share exchange with AnorTech Inc., acquiring approximately 9.9% of AnorTech's outstanding common stock for $3.7 million.
As of June 30, 2026, Greenland Mines had cash and cash equivalents of approximately $9.3 million, a significant increase from $7.2 million at the end of 2025. The company is actively seeking additional funding to support its operations and future acquisitions, including a pending merger with Neo North Star Resources, which requires $20 million in cash. The company has expressed concerns about its ability to continue as a going concern without securing further financing, given its accumulated deficit of approximately $39 million and ongoing operational losses.
Looking ahead, Greenland Mines is focused on advancing its exploration activities at the Skaergaard Project and continuing its research and development efforts in biotechnology. The company is also addressing compliance issues with Nasdaq regarding its minimum bid price requirement, with a compliance deadline set for September 14, 2026. The board has been authorized to implement a reverse stock split if necessary to regain compliance.
About Greenland Mines Ltd
Klotho Neurosciences develops innovative cell and gene therapies targeting age-related neurodegenerative diseases like Alzheimer's and ALS. Its proprietary platforms include gene therapy approaches to increase Klotho protein levels, aiming to prevent neuronal decline and improve cognitive function. The company also licenses biosimilar biologics and generic drugs for cancer treatment, focusing on advancing therapies that address aging and chronic diseases in global markets.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov